Abselion raises 6.6 million to transform protein quantification
BGF - 05-Dec-2024Investors back Amperia for faster, more accessible protein measurement
The Live Forever Club is evolving. Subscribe to the newsletter to be the first to hear about this important change.
Strategic corporate venture capital in Biotech & Tech
M Ventures is the strategic corporate venture capital arm of Merck KGaA, Darmstadt, Germany, investing globally in transformative ideas across healthcare drug development, life science tools, electronics, and frontier technology & sustainability. With a fund allocation of €600 million, M Ventures actively collaborates with entrepreneurs and co-investors to translate scientific discoveries into commercial success.
Visit website: https://www.m-ventures.com/
Details last updated 12-Feb-2025
Investors back Amperia for faster, more accessible protein measurement